The Department of Health and Human Services referred scores of hospitals, physician groups, pharmacies, and pharmacy benefit managers to federal investigators over insurance claims filed for gender related care in minors. The referrals, announced on August 13, name some of the largest health systems in the country and mark the widest enforcement action yet in an ongoing federal effort targeting pediatric gender medicine.
A referral is not a charge. It is a request that investigators look, and the distinction matters for anyone reading a hospital's name on the list. HHS Secretary Robert F. Kennedy Jr. referred organizations to the department's Office of Inspector General, while Vice President JD Vance, who chairs a White House anti-fraud task force, referred entities to the Justice Department. The HHS referral letter to the Inspector General describes the claims as showing "potentially anomalous billing patterns."
For patients and families, the immediate question is narrower than the political one. It is whether the hospital they use is on the list, and what happens to their care if it is.
The Coding Allegation at the Center of the Referrals
The referrals stem from an HHS report analyzing insurance claims data from 2015 through 2025. The report focuses on two diagnostic codes rather than on the treatments themselves.
The first is the code for unspecified endocrine disorder. HHS says providers billed puberty blockers for minors aged nine to 17 under that code on claims that carried neither a gender dysphoria diagnosis nor a precocious puberty diagnosis. The department put approximately $50 million in claims in that category. The second is the code for precocious puberty, a condition in which puberty begins unusually early. HHS identified nearly $11 million billed for puberty blockers prescribed under that code to patients aged 13 to 17, an age range it says falls outside what the diagnosis describes.
A third group covers providers that billed a primary gender dysphoria diagnosis alongside a cross sex hormone prescription written the same day, for patients 17 or younger, in states where such care was prohibited at the time.
The referral letter names organizations including Kaiser entities, HCA, Providence, NYU Langone, Scott and White, CVS Caremark, Walgreens, Accredo, Optum, CenterWell, Prime Therapeutics, and multiple Planned Parenthood affiliates. Boston Children's Hospital, which appears in the letter, said it is reviewing the report. HHS separately said that more than 225 hospitals and health systems have established pediatric gender programs nationwide, a figure that describes the field rather than the referral list.
Inside the OIG Referral Process
An OIG referral starts an administrative process. Investigators can examine claims data and the underlying medical records that support them. Depending on findings, outcomes can include no action, repayment demands, civil enforcement under the False Claims Act, exclusion from federal health programs, or referral for criminal prosecution.
None of that is automatic, and none of it is fast. Federal health care fraud investigations routinely run for years before resolving, and many close without public action.
The Justice Department referrals operate on a separate track. Three hospitals have already reached agreements with the department and stopped providing gender related services to minors: Texas Children's Hospital, the Cleveland Clinic Foundation, and most recently Connecticut Children's Medical Center, which agreed to a monetary penalty and to set aside $500,000 in care for former patients. The department said there was no determination of liability, and the hospital denied the allegations.
There is also relevant history in the report itself. HHS cites the Texas Attorney General's investigation into Texas Children's Hospital, which resulted in a $10 million settlement reached in May 2026, in coordination with the Justice Department and executed this month. That matter is separate from these referrals.
The Practical Effect on Patients and Families
Families with a child receiving care at a named institution should expect uncertainty rather than an immediate change. Referrals do not suspend services. But institutions under federal investigation frequently make their own decisions about risk, and several health systems have discontinued pediatric gender services in recent months following earlier federal actions.
The financial layer moved separately. MedicalDaily reported on a CMS final rule cutting federal Medicaid and CHIP matching funds for certain gender related interventions in minors, which was finalized days before these referrals. That rule withdraws the federal share of payment. It does not prohibit states from covering the same services with state dollars alone.
Families whose care is affected should contact their treating clinician about continuity planning, ask their state Medicaid agency directly what remains covered in their area, and request copies of their child's medical records before any transition. Records requests are a patient right and are worth making early rather than after a clinic closes a service line.
Where the Medical Organizations Stand
The administration's position that these treatments are dangerous is at odds with the stated positions of most major American medical associations, including the American Academy of Pediatrics, the American Medical Association, and the American Psychiatric Association, which continue to support access to this care under clinical guidelines.
That disagreement is not resolved by a billing analysis, and the referrals do not attempt to resolve it. What the referrals allege is a coding question: whether the diagnosis submitted to an insurer accurately described the reason for the treatment. Coding disputes are common in health care and are frequently resolved without a finding of fraud, because diagnosis selection often reflects clinical judgment, payer policy, and software defaults rather than intent.
The report was commissioned by HHS, draws in part on data from Do No Harm, an advocacy organization that opposes this care, and was co-authored by people affiliated with the Independent Women's Forum. Readers evaluating the findings should weigh them alongside the claims analysis itself.
The OIG and the Justice Department will decide independently whether to open formal investigations, and neither is required to announce that decision. Named organizations may issue statements or contest the characterization of their billing. State attorneys general in states with and without care bans may act separately.
CMS guidance implementing the Medicaid rule is the development most likely to change what families actually pay. That is the document to watch.
Key Questions Answered
Does a referral mean a hospital committed fraud?
No. A referral asks investigators to examine claims. It is not an indictment, a charge, a conviction, or a finding of liability.
What did HHS actually allege?
That providers billed puberty blockers for minors under codes for unspecified endocrine disorder or precocious puberty rather than gender dysphoria, across approximately $50 million and nearly $11 million in claims, respectively.
Will my child's appointments be canceled?
Not automatically. Referrals do not suspend services. Some health systems have independently discontinued pediatric gender services following earlier federal actions, so families should confirm directly with their clinician.
Which organizations were named?
Large health systems including Kaiser entities, HCA, Providence, NYU Langone and Scott and White, plus pharmacy benefit managers, specialty pharmacies, children's hospitals and Planned Parenthood affiliates.
How long will an investigation take?
Federal health care investigations often take years. Many close without public action. There is no announced timeline.
Is this the same as the Medicaid funding rule?
No. The CMS rule withdraws federal matching funds for certain services and takes effect on its own schedule. The referrals are part of an enforcement action regarding past billing.
What should families do now?
Ask the treating clinician about continuity of care, contact the state Medicaid agency in the state where they live about coverage, and request copies of medical records.
